Iron Levels in Hepatocytes and Portal Tract Cells Predict Progression and Outcomes of Patients With Advanced Chronic Hepatitis C
- 1 May 2011
- journal article
- research article
- Published by Elsevier in Gastroenterology
- Vol. 140 (5) , 1490-1500.e3
- https://doi.org/10.1053/j.gastro.2011.01.053
Abstract
No abstract availableKeywords
Funding Information
- University of Massachusetts Medical Center
- University of Connecticut Health Center (M01RR-06192)
- Saint Louis University School of Medicine
- Massachusetts General Hospital (M01RR-01066, 1 UL1 RR025758-01)
- University of Colorado Denver, School of Medicine (M01RR-00051, 1 UL1 RR 025780-01)
- University of California-Irvine (M01RR-00827)
- University of Texas Southwestern Medical Center (M01RR-00633, 1 UL1 RR024982-01)
- University of Southern California (M01RR-00043)
- University of Michigan Medical Center (M01RR-00042, 1 UL1 RR024986)
- Virginia Commonwealth University Health System (M01RR-00065)
- Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases, Division of Digestive Diseases and Nutrition
- University of Washington
- New England Research Institutes
- Inova Fairfax Hospital
This publication has 41 references indexed in Scilit:
- Predicting Clinical and Histologic Outcomes Based on Standard Laboratory Tests in Advanced Chronic Hepatitis CGastroenterology, 2010
- Prolonged Therapy of Advanced Chronic Hepatitis C with Low-Dose PeginterferonNew England Journal of Medicine, 2008
- Hepatitis C virus–induced oxidative stress suppresses hepcidin expression through increased histone deacetylase activityHepatology, 2008
- The Serine Protease TMPRSS6 Is Required to Sense Iron DeficiencyScience, 2008
- Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA)Nature Genetics, 2008
- Phlebotomy Improves Therapeutic Response to Interferon in Patients with Chronic Hepatitis C: A Meta-Analysis of Six Prospective Randomized Controlled TrialsDigestive Diseases and Sciences, 2007
- Hepatitis C Virus–Specific Immune Responses and Quasi‐Species Variability at Baseline Are Associated with Nonresponse to Antiviral Therapy during Advanced Hepatitis CThe Journal of Infectious Diseases, 2006
- Hemochromatosis and Iron-Overload Screening in a Racially Diverse PopulationNew England Journal of Medicine, 2005
- Histological grading and staging of chronic hepatitisJournal of Hepatology, 1995
- Liver fibrosis in genetic hemochromatosisJournal of Hepatology, 1992